Testing effectiveness (Phase 2)Study completedNCT03798366
What this trial is testing
A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis
Who this might be right for
Systemic Sclerosis
Lakefront Biotherapeutics NV 33